AUTHOR INDEX
| |
|
|
|
|
|
Search results for: "S"
Results 11 - 20 of 1023 shown below |
|
| Saber, Andrea J |
|
| Andrea J Saber and Donald P Cain Combined -Adrenergic and Cholinergic Antagonism Produces Behavioral and Cognitive Impairments in the Water Maze: Implications for Alzheimer Disease and Pharmacotherapy with -Adrenergic Antagonistsdoi:10.1038/sj.npp.1300163 Neuropsychopharmacology 28, 1247-1256 | Abstract | Full text | PDF | |
|
| Sabino, Valentina |
|
| Pietro Cottone, Valentina Sabino, Luca Steardo and Eric P Zorrilla FG 7142 Specifically Reduces Meal Size and the Rate and Regularity of Sustained Feeding in Female Rats: Evidence that Benzodiazepine Inverse Agonists Reduce Food Palatability doi:10.1038/sj.npp.1301229 Neuropsychopharmacology 32, 1069-1081 | Abstract | Full text | PDF | |
|
| Pietro Cottone, Valentina Sabino, Luca Steardo and Eric P Zorrilla Opioid-Dependent Anticipatory Negative Contrast and Binge-Like Eating in Rats with Limited Access to Highly Preferred Food doi:10.1038/sj.npp.1301430 Neuropsychopharmacology 33, 524-535 | Abstract | Full text | PDF | |
|
| Valentina Sabino, Pietro Cottone, Yu Zhao, Malliga R Iyer, Luca Steardo, Luca Steardo, Kenner C Rice, Bruno Conti, George F Koob and Eric P Zorrilla The -Receptor Antagonist BD-1063 Decreases Ethanol Intake and Reinforcement in Animal Models of Excessive Drinkingdoi:10.1038/npp.2008.192 Neuropsychopharmacology 34, 1482-1493 | Abstract | Full text | PDF | |
|
| Sabri, O |
|
| P Brust, R Hinz, H Kuwabara, S Hesse, J Zessin, B Pawelke, H Stephan, R Bergmann, J Steinbach and O Sabri In vivo Measurement of the Serotonin Transporter with (S)-([18F]fluoromethyl)-(+)-McN5652 doi:10.1038/sj.npp.1300281 Neuropsychopharmacology 28, 2010-2019 | Abstract | Full text | PDF | |
|
| Sabri, Osama |
|
| Euphrosyne Gouzoulis-Mayfrank, Mathias Schreckenberger, Osama Sabri, Christoph Arning, Bernhard Thelen, Manfred Spitzer, Karl-Artur Kovar, Leopold Hermle, Udalrich Büll and Henning Sass Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG doi:10.1016/S0893-133X(98)00089-X Neuropsychopharmacology 20, 565-581 | Abstract | Full text | PDF | |
|
| Sacchetti, Lucia |
|
| Valentina De Chiara, Francesco Errico, Alessandra Musella, Silvia Rossi, Giorgia Mataluni, Lucia Sacchetti, Alberto Siracusano, Maura Castelli, Francesca Cavasinni, Giorgio Bernardi, Alessandro Usiello and Diego Centonze Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum doi:10.1038/npp.2009.141 Neuropsychopharmacology aop, - | Abstract | Full text | PDF | |
|
| Sacher, Julia |
|
| Julia Sacher, Nilufar Mossaheb, Christoph Spindelegger, Nikolas Klein, Thomas Geiss-Granadia, Robert Sauermann, Edith Lackner, Christian Joukhadar, Markus Müller and Siegfried Kasper Effects of Olanzapine and Ziprasidone on Glucose Tolerance in Healthy Volunteers doi:10.1038/sj.npp.1301541 Neuropsychopharmacology 33, 1633-1641 | Abstract | Full text | PDF | |
|
| Sackeim, Harold A |
|
| Sarah H Lisanby, Bruce Luber, Thomas E Schlaepfer and Harold A Sackeim Safety and Feasibility of Magnetic Seizure Therapy (MST) in Major Depression: Randomized Within-Subject Comparison with Electroconvulsive Therapy doi:10.1038/sj.npp.1300229 Neuropsychopharmacology 28, 1852-1865 | Abstract | Full text | PDF | |
|
| Tarique D Perera, Bruce Luber, Mitchell S Nobler, Joan Prudic, Christopher Anderson and Harold A Sackeim Seizure Expression During Electroconvulsive Therapy: Relationships with Clinical Outcome and Cognitive Side Effects doi:10.1038/sj.npp.1300377 Neuropsychopharmacology 29, 813-825 | Abstract | Full text | PDF | |
|
| A John Rush, Helena C Kraemer, Harold A Sackeim, Maurizio Fava, Madhukar H Trivedi, Ellen Frank, Philip T Ninan, Michael E Thase, Alan J Gelenberg, David J Kupfer, Darrel A Regier, Jerrold F Rosenbaum, Oakley Ray and Alan F Schatzberg Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder doi:10.1038/sj.npp.1301131 Neuropsychopharmacology 31, 1841-1853 | Abstract | Full text | PDF | |
|
| Harold A Sackeim, Joan Prudic, Rice Fuller, John Keilp, Philip W Lavori and Mark Olfson The Cognitive Effects of Electroconvulsive Therapy in Community Settings doi:10.1038/sj.npp.1301180 Neuropsychopharmacology 32, 244-254 | Abstract | Full text | PDF | |
|
| Joan Prudic, Linda Fitzsimons, Mitchell S Nobler and Harold A Sackeim Naloxone in the Prevention of the Adverse Cognitive Effects of ECT: A Within-Subject, Placebo Controlled Study doi:10.1016/S0893-133X(99)00015-9 Neuropsychopharmacology 21, 285-293 | Abstract | Full text | PDF | |
|
| Harold A Sackeim, A John Rush, Mark S George, Lauren B Marangell, Mustafa M Husain, Ziad Nahas, Christopher R Johnson, Stuart Seidman, Cole Giller, Stephen Haines, Richard K Simpson and Robert R Goodman Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome doi:10.1016/S0893-133X(01)00271-8 Neuropsychopharmacology 25, 713-728 | Abstract | Full text | PDF | |
|
| Sarah H Lisanby, Mustafa M Husain, Peter B Rosenquist, Daniel Maixner, Rosben Gutierrez, Andrew Krystal, William Gilmer, Lauren B Marangell, Scott Aaronson, Zafiris J Daskalakis, Randolph Canterbury, Elliott Richelson, Harold A Sackeim and Mark S George Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial doi:10.1038/npp.2008.118 Neuropsychopharmacology 34, 522-534 | Abstract | Full text | PDF | |
|
| Sacquet, Joëlle |
|
| Alexandra Veyrac, Joëlle Sacquet, Véronique Nguyen, Marc Marien, François Jourdan and Anne Didier Novelty Determines the Effects of Olfactory Enrichment on Memory and Neurogenesis Through Noradrenergic Mechanisms doi:10.1038/npp.2008.191 Neuropsychopharmacology 34, 786-795 | Abstract | Full text | PDF | |
|
| Safarinejad, Mohammad R |
|
| Mohammad R Safarinejad Safety and Efficacy of Dapoxetine in the Treatment of Premature Ejaculation: A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized Study doi:10.1038/sj.npp.1301500 Neuropsychopharmacology 33, 1259-1265 | Abstract | Full text | PDF | |
|
| Mohammad R Safarinejad Reply: Dapoxetine in Premature Ejaculation doi:10.1038/npp.2008.12 Neuropsychopharmacology aop, - | Abstract | Full text | PDF | |
|
| Sage, Jennifer R |
|
| Stephan G Anagnostaras, Stephen Maren, Jennifer R Sage, Stacy Goodrich and Michael S Fanselow Scopolamine and Pavlovian Fear Conditioning in Rats: Dose-Effect Analysis doi:10.1016/S0893-133X(99)00083-4 Neuropsychopharmacology 21, 731-744 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | |
|
| top |
|

-Adrenergic and Cholinergic Antagonism Produces Behavioral and Cognitive Impairments in the Water Maze: Implications for Alzheimer Disease and Pharmacotherapy with
-Receptor Antagonist BD-1063 Decreases Ethanol Intake and Reinforcement in Animal Models of Excessive Drinking
